LEN Lennar Corporation Class A

Lennar Partners with Laurel & Wolf to Showcase their Online Interior Design Services at The San Francisco Shipyard

Lennar is excited to announce their partnership with leading online interior design service Laurel & Wolf. As part of the partnership, Lennar will include a Laurel & Wolf Signature Design Package which allows you to work one-on-one with a professional interior designer for a room of your choice for a limited time* with a new home purchase at The San Francisco Shipyard. With three communities now selling, Alma, Engel and Thayer, The San Francisco Shipyard offers a great opportunity to live in one of the hottest markets nationwide starting from the low $600,000’s.

“We are thrilled to be partnering with Laurel & Wolf, and adding this unique online interior design service to our Everything’s Included® package at The San Francisco Shipyard,” said Morgan Sterling, Marketing Manager for Lennar Bay Area. “We encourage everyone to come and see Laurel & Wolf’s professionally designed model homes at this historic setting.”

With Laurel & Wolf’s Signature Design Package, you get connected with a marketplace of professional interior designers. In a few easy steps, you work one-on-one with the designer of your choice entirely online to create the perfect design that fits your tastes, needs and budget. Find your place at The San Francisco Shipyard, then, find your style with a Laurel & Wolf Signature Design Package.

Alma is a collection of luxury townhomes that range in size from approximately 1,072 to 1,437 square feet, two to three bedrooms and two-and-a-half bathrooms. Select townhomes feature private balconies and decks, some with gorgeous city skyline views.

Engel is a collection of exquisite flats that range in size from approximately 603 to 1,342 square feet, one to three bedrooms and one to two bathrooms. Many homes have private terraces and shared rooftop decks.

Thayer is a collection of Edwardian-inspired flats that range from approximately 957 to 970 square feet, one to two bedrooms and one to two bathrooms. These attached homes have shared terrace spaces.

In addition to offering a Laurel & Wolf Signature Design Package, all three communities feature Lennar’s Everything’s Included® program which puts upscale features such as dark hardwood flooring throughout the kitchen and living areas, gorgeous Caesarstone® kitchen countertops, stainless steel Bosch® appliances, upgraded cabinetry and much more into every new home they build at no additional cost!

Set in the historic naval shipyard location, residents enjoy great amenities in this mixed-use community, including a specialty general store, parks, public artwork installations and a daily shuttle that commutes to downtown San Francisco with stops along the Third Street Corridor, Dogpatch, Soma and CalTrain. For public transit, the 19 MUNI line and T Third Street light rail connect to the rest of the city’s transportation system.

The San Francisco Shipyard’s Welcome Home Center is open daily from 11 a.m. to 6 p.m. at 11 Innes Court. Visit www.lennar.com/thesfshipyard for directions or to schedule a tour.

With hundreds of communities nationwide and homes designed for first-time, move-up and luxury homebuyers, Lennar has grown to become one of the nation’s leading and most respected homebuilders and proudly remains steadfast in their commitment toward quality, value and integrity. Lennar has a longstanding history of building exceptional homes in only the most well planned and desirable locations throughout the country.

* Offer good for a limited time only. Lennar reserves the right to change or withdraw any offer at any time. Lennar Homes of California, Inc. License #728102. Lennar Sales Corp. California Bureau of Real Estate License #01252753. Equal Housing Opportunity. 9/16

EN
15/09/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Lennar Corporation Class A

Lennar Corp: 1 director

A director at Lennar Corp bought 1,575 shares at 157.000USD and the significance rating of the trade was 53/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

Wedbush Research
  • Wedbush Research
LOGN LOGITECH INTERNATIONAL S.A.
KMX CARMAX INC.
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
SGMO SANGAMO THERAPEUTICS INC.
RHP RYMAN HOSPITALITY PROPERTIES INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
PCRX PACIRA BIOSCIENCES INC.
NVCR NOVOCURE LTD.
NCMI NATIONAL CINEMEDIA INC.
NBIX NEUROCRINE BIOSCIENCES INC.
MTH MERITAGE HOMES CORPORATION
LGIH LGI HOMES INC.
LEN LENNAR CORPORATION CLASS A
KURA KURA ONCOLOGY INC.
KPTI KARYOPHARM THERAPEUTICS
IMAX IMAX CORPORATION
GPRO GOPRO INC. CLASS A
GOOGL ALPHABET INC. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CNK CINEMARK HOLDINGS INC.
CMRX CHIMERIX INC
CCS CENTURY COMMUNITIES INC.
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
ARDX ARDELYX INC
AMC AMC ENTERTAINMENT HOLDINGS INC. CLASS A
NFLX NETFLIX INC.
DHI D.R. HORTON INC.
FRX_CN FENNEC PHARMACEUTICALS
PVH PVH CORP.
UTHR UNITED THERAPEUTICS CORPORATION
CLSD CLEARSIDE BIOMEDICAL INC
ALBO ALBIREO PHARMA
ANAB ANAPTYSBIO INC.
KALA KALA PHARMACEUTICALS INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
GTHX G1 THERAPEUTICS
ALPN ALPINE IMMUNE SCIENCES
ROKU ROKU INC. CLASS A
AMZN AMAZON.COM INC.
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SURF SURFACE ONCOLOGY
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
LQDA LIQUIDIA CORPORATION
REPL REPLIMUNE GROUP
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
BCEL ATRECA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
AQST AQUESTIVE THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
PRAX PRAXIS PRECISION MEDICINES
FUBO FUBOTV
CURA CURALEAF HOLDINGS
TVTX TRAVERE THERAPEUTICS INC
VRDN VIRIDIAN THERAPEUTICS INC
DAWN DAY ONE BIOPHARMACEUTICALS INC
ELEV ELEVATION ONCOLOGY
OMGA OMEGA THERAPEUTICS
LBPH LONGBOARD PHARMACEUTICALS
THRX THESEUS PHARMACEUTICALS
DSGN INC.
ATXS DESIGN THERAPEUTICS INC
AVTE ASTRIA THERAPEUTICS INC
RLYB AEROVATE THERAPEUTICS INC
KRTX RALLYBIO CORP
FUSN KARUNA THERAPEUTICS INC
VIGL FUSION PHARMACEUTICALS INC
EWTX VIGIL NEUROSCIENCE INC
EDGEWISE THERAPEUTICS INC
Brian Violino ... (+2)
  • Brian Violino
  • Jay McCanless

ResearchPool Subscriptions

Get the most out of your insights

Get in touch